Finzati - Logo
TMDX logo

TransMedics Group, Inc.

TMDX • Medical - Devices
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$2.64B
Growth
51.3%
Cash Flow
1/5
Trend
Volatile
Evidence
Stable or improving margins · 31.4%Positive revenue growth · 100.8%Positive free cash flow · 3.93Reasonable earnings multiple · 21.73Healthy liquidity · 7.14
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:51 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$2.64B
52W Range60.10 - 156.00
Beta1.88
Gross Margin59.92%
Oper. Margin17.93%
Profit Margin31.43%
Debt/Eq0.99
Current Ratio7.14
Quick Ratio6.59
Revenue 5Y51.29%

Investment DNA

How strong this company looks for long-term investors

74
out of 100
Business Quality
Margins, moat, returns
84/100
Financial Strength
Debt, cash, stability
83/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
41/100
Why this score▼
Stable or improving margins · 31.4%Positive revenue growth · 100.8%Positive free cash flow · 3.93Reasonable earnings multiple · 21.73Healthy liquidity · 7.14

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$65.00
Mean
$96.86
Median
$95.00
High
$122.00

Company Overview

IPO: 5/2/2019
Industry: Medical - Devices
P/B i: 8.74
Debt / Equity i: 0.99
Operating Margin: 17.93%
Net Margin: 31.43%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.99
Current Ratio: 7.14
Quick Ratio: 6.59
Status: Strong

Insider Transactions

Recent executive and insider activity

Hassanein Waleed H
Transaction: 07/10/2026
BUY
Change
+112,984
Price
$71.23
Filing
07/14/2026
Type
BUY
Hassanein Waleed H
Transaction: 07/10/2026
BUY
Change
+49,669
Price
Not reported
Filing
07/14/2026
Type
BUY
Hernandez Gerardo
Transaction: 07/10/2026
BUY
Change
+26,153
Price
$71.23
Filing
07/14/2026
Type
BUY